While speech interaction finds widespread utility within the Extended Reality (XR) domain, conventional vocal speech keyword spotting systems continue to grapple with formidable challenges, including ...

REDWOOD CITY, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, ...

The RayNeo Air 3S is available for $269 These XR glasses provide advanced micro-OLED screens, dual speaker chamber design, and a 201-inch screen visual experience There are no light-blocking ...

Sitagliptin inhibits plasma DPP-4 activity in a dose-dependent manner. [12] After an oral glucose load or a meal, sitagliptin increases circulating levels of active GLP-1 and GIP by two-to ...

Sitagliptin is a new oral agent approved by the FDA to treat patients with type 2 diabetes who have inadequate glycemic control on diet and exercise or on pioglitazone or metformin monotherapy.

MSD’s sitagliptin and its combinations are marketed in India under the brand names Januvia, Janumet, and Janumet XR. The two American pharmaceutical giants will join hands to leverage Abbott’s ...

MSD's sitagliptin, its combination and extended-release versions are marketed under the brand names Januvia, Janumet and Janumet XR. Abbott will leverage its broad in-country footprint to continue to ...